HSBC Holdings’s BioTelemetry, Inc. BEAT Stock Holding History

HSBC Holdings’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,700	Closed	-$554K	–	3312
2020 Q4	$554K	Buy	+7,700	New	+$403K	﹤0.01%	2125
2020 Q1	–	Sell	-8,405	Closed	-$394K	–	3182
2019 Q4	$394K	Buy	8,405 +1,525	+22%	+$66K	﹤0.01%	2373
2019 Q3	$280K	Buy	6,880 +2,328	+51%	+$101K	﹤0.01%	2671
2019 Q2	$219K	Sell	4,552 -1,198	-21%	-$63K	﹤0.01%	2501
2019 Q1	$360K	Buy	+5,750	New	+$395K	﹤0.01%	2258

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

HSBC Holdings's BEAT Position: Q1 2021 in Review

HSBC Holdings sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 7,700 shares — an estimated $554K sold.

HSBC Holdings first reported a position in BEAT in Q1 2019 and held it in 5 quarters. The position peaked at $554K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

HSBC Holdings reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
HSBC Holdings sold 7,700 BioTelemetry, Inc. shares in Q1 2021, an estimated $554K.
HSBC Holdings first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 5 quarters.
HSBC Holdings's BioTelemetry, Inc. position peaked at $554K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.